Uterine neoplasms in patients treated with tamoxifen

Elvio G. Silva; Carmen Tornos; Anais Malpica; Michele Follen Mitchell

doi:10.1002/jcb.240590924

Uterine neoplasms in patients treated with tamoxifen

Elvio G. Silva, Carmen Tornos, Anais Malpica, Michele Follen Mitchell

Pathology

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Since 1985, when Killackey originally described three cases of endometrial carcinoma in patients receiving tamoxifen, there have been several reports confirming or denying the relationship between tamoxifen and endometrial carcinoma. Our study of 15 patients treated for breast carcinoma with tamoxifen found that papillary serous carcinoma was the most common tumor in this group of patients. Several other retrospecitive studies reported a high incidence of high‐grade endometrioid adenocarcinoma or high‐risk variants of endometrial carcinoma in patients receiving tamoxifen.

Original language	English (US)
Pages (from-to)	179-183
Number of pages	5
Journal	Journal of cellular biochemistry
Volume	59
Issue number	23 S
DOIs	https://doi.org/10.1002/jcb.240590924
State	Published - 1995

Keywords

Tamoxifen
uterine neoplasms

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Cell Biology

Access to Document

10.1002/jcb.240590924

Cite this

@article{6dd7016ee84e4252ac0e923e1e4aef18,

title = "Uterine neoplasms in patients treated with tamoxifen",

abstract = "Since 1985, when Killackey originally described three cases of endometrial carcinoma in patients receiving tamoxifen, there have been several reports confirming or denying the relationship between tamoxifen and endometrial carcinoma. Our study of 15 patients treated for breast carcinoma with tamoxifen found that papillary serous carcinoma was the most common tumor in this group of patients. Several other retrospecitive studies reported a high incidence of high‐grade endometrioid adenocarcinoma or high‐risk variants of endometrial carcinoma in patients receiving tamoxifen.",

keywords = "Tamoxifen, uterine neoplasms",

author = "Silva, {Elvio G.} and Carmen Tornos and Anais Malpica and Mitchell, {Michele Follen}",

year = "1995",

doi = "10.1002/jcb.240590924",

language = "English (US)",

volume = "59",

pages = "179--183",

journal = "Journal of cellular biochemistry",

issn = "0730-2312",

publisher = "Wiley-Liss Inc.",

number = "23 S",

}

TY - JOUR

T1 - Uterine neoplasms in patients treated with tamoxifen

AU - Silva, Elvio G.

AU - Tornos, Carmen

AU - Malpica, Anais

AU - Mitchell, Michele Follen

PY - 1995

Y1 - 1995

N2 - Since 1985, when Killackey originally described three cases of endometrial carcinoma in patients receiving tamoxifen, there have been several reports confirming or denying the relationship between tamoxifen and endometrial carcinoma. Our study of 15 patients treated for breast carcinoma with tamoxifen found that papillary serous carcinoma was the most common tumor in this group of patients. Several other retrospecitive studies reported a high incidence of high‐grade endometrioid adenocarcinoma or high‐risk variants of endometrial carcinoma in patients receiving tamoxifen.

AB - Since 1985, when Killackey originally described three cases of endometrial carcinoma in patients receiving tamoxifen, there have been several reports confirming or denying the relationship between tamoxifen and endometrial carcinoma. Our study of 15 patients treated for breast carcinoma with tamoxifen found that papillary serous carcinoma was the most common tumor in this group of patients. Several other retrospecitive studies reported a high incidence of high‐grade endometrioid adenocarcinoma or high‐risk variants of endometrial carcinoma in patients receiving tamoxifen.

KW - Tamoxifen

KW - uterine neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0029438912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029438912&partnerID=8YFLogxK

U2 - 10.1002/jcb.240590924

DO - 10.1002/jcb.240590924

M3 - Article

C2 - 8747394

AN - SCOPUS:0029438912

SN - 0730-2312

VL - 59

SP - 179

EP - 183

JO - Journal of cellular biochemistry

JF - Journal of cellular biochemistry

IS - 23 S

ER -

Uterine neoplasms in patients treated with tamoxifen

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this